Cargando…
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...
Autores principales: | Burns, Madeleine D, Boribong, Brittany P, Bartsch, Yannic C, Loiselle, Maggie, Davis, Jameson P, Lima, Rosiane, Edlow, Andrea G, Fasano, Alessio, Alter, Galit, Yonker, Lael M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863160/ https://www.ncbi.nlm.nih.gov/pubmed/35194616 http://dx.doi.org/10.1101/2022.01.05.22268617 |
Ejemplares similares
-
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children
por: Burns, Madeleine D., et al.
Publicado: (2022) -
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023) -
Comprehensive antibody profiling of mRNA vaccination in children
por: Bartsch, Yannic C, et al.
Publicado: (2022) -
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
por: Bartsch, Yannic C, et al.
Publicado: (2022) -
Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Boribong, Brittany P., et al.
Publicado: (2021)